The Waters Corporation and Andrew Alliance have signed a co-marketing agreement to promote their collaboration on protein therapeutics glycosylation profiling. The partnership enables laboratories to automate large numbers of routine, high-quality released N-glycan analyses with improved accuracy and precision.
The Waters nanoEase M/Z columns offer streamlined installation using ZenFit Connection Technology, reducing chromatographic variability. These columns deliver superior performance in proteomics and biomarker research applications.
Waters Corporation is offering complimentary drinking water analysis to US water authorities to assess regional exposure and develop solutions for pharmaceutical residues. The program aims to provide a baseline understanding of exposure levels to facilitate long-term monitoring and action plans.